Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis - Camille V. Edwards; Nisha Rao; Divaya Bhutani; Markus Y. Mapara; Jai Radhakrishnan; Sofia Shames; Mathew S. Maurer; Siyang Leng; Alan Solomon; Suzanne Lentzsch; Andrew Eisenberger (2021)